Abstract

Background: Limited data on electronic cigarette prevalence, patterns, and settings of use are available from several European countries.

Methods: Within the TackSHS project, a face-to-face survey was conducted in 2017–2018 in 12 European countries (Bulgaria, England, France, Germany, Greece, Ireland, Italy, Latvia, Poland, Portugal, Romania and Spain). Overall, 11,876 participants, representative of the population aged ⩾15 years in each country, provided information on electronic cigarette.

Results: 2.4% (95% confidence interval [CI], 2.2–2.7%) of the subjects (2.5% among men and 2.4% among women; 0.4% among never, 4.4% among current- and 6.5% among ex-smokers) reported current use of electronic cigarette, ranging from 0.6% in Spain to 7.2% in England. Of the 272 electronic cigarette users, 52.6% were dual users (ie, users of both electronic and conventional cigarettes) and 58.8% used liquids with nicotine. In all, 65.1% reported using electronic cigarette in at least one indoor setting where smoking is forbidden; in particular, at workplaces (34.9%) and bars and restaurants (41.5%). Multivariable logistic regression analysis showed that electronic cigarette use was lower among older individuals (P for trend <0.001) and higher among individuals with high level of education (P for trend = 0.040). Participants from countries with higher tobacco cigarette prices more frequently reported electronic cigarette use (odds ratio 3.62; 95% CI, 1.80–7.30).

Conclusion: Considering the whole adult population of these 12 European countries, more than 8.3 million people use electronic cigarettes. The majority of users also smoked conventional cigarettes, used electronic cigarettes with nicotine, and consumed electronic cigarettes in smoke-free indoor areas.

Details

Title
Electronic Cigarette Use in 12 European Countries: Results From the TackSHS Survey
Author
Gallus, Silvano  VIAFID ORCID Logo  ; Lugo, Alessandra  VIAFID ORCID Logo  ; Chiara Stival Department of Environmental Health Sciences, Istituto di Ricerche Farmacologiche Mario Negri IRCCS; Sonia Cerrai Epidemiology and Health Research Lab, Institute of Clinical Physiology, National Research Council of Italy (IFC-CNR); Luke Clancy TobaccoFree Research Institute Ireland; Filippos T Filippidis Department of Primary Care and Public Health, Imperial College London; Giuseppe Gorini Oncologic Network, Prevention and Research Institute (ISPRO); Maria José Lopez Agència de Salut Pública de Barcelona Departament de Ciències Experimentals i de la Salut (DCEXS), Universitat Pompeu Fabra Consortium for Biomedical Research in Epidemiology and Public Health (CIBERESP) Sant Pau Institute of Biomedical Research (IIB Sant Pau); Ángel López-Nicolás Polytechnic University of Cartagena (UPCT); Sabrina Molinaro Epidemiology and Health Research Lab, Institute of Clinical Physiology, National Research Council of Italy (IFC-CNR); Anna Odone School of Medicine, University Vita-Salute San Raffaele Department of Public Health, Experimental and Forensic Medicine, University of Pavia; Joan B Soriano Hospital Universitario La Princesa (IISP) Consortium for Biomedical Research in Respiratory Diseases (CIBERES); Tigova, Olena  VIAFID ORCID Logo  ; Piet A van den Brandt Maastricht University Medical Centre, GROW- School for Oncology and Developmental Biology, Department of Epidemiology Maastricht University Medical Centre, CAPHRI- School for Public Health and Primary Care, Department of Epidemiology; Constantine I Vardavas Hellenic Cancer Society School of Medicine, University of Crete; Esteve Fernandez Consortium for Biomedical Research in Respiratory Diseases (CIBERES) Tobacco Control Research Group, Epidemiology and Public Health Research Programme, Institut d’Investigació Biomèdica de Bellvitge-IDIBELL Tobacco Control Unit, WHO collaborating center on tobacco control, Institut Català d’Oncologia-ICO School of Medicine and Health Sciences, Campus of Bellvitge, Universitat de Barcelona
Pages
276-284
Section
Original Article
Publication year
2022
Publication date
2022
Publisher
Japan Epidemiological Association
ISSN
09175040
e-ISSN
13499092
Source type
Scholarly Journal
Language of publication
English
ProQuest document ID
2822800951
Copyright
© 2022. This work is published under https://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.